jzp150
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Nov 1, 2004 (NCT00097708)
Timeline
Indications
Mechanism of action
- Anandamide amidohydrolaseANTAGONIST
FAAH antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- jazz pharma experimental anti-anxiety drug
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05178316 | Phase 2 | Dec 29, 2021 | Jazz Pharmaceuticals |
| NCT00097708 | Phase 3 | Nov 1, 2004 | Jazz Pharmaceuticals, University of California, San Diego |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals | For profit | 2 | 2 | 2 | 2004 |
| University of California, San Diego | Academic/Hospital | 1 | 0 | 1 | 2004 |
2 organizations
Page 1 / 1